Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population-Reference-Cited by-同舟云学术

Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population

Published:2018-02-16 Issue:7 Volume:40 Page:1425-1433
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Chan Sze Ling¹,Ng Li Shia²,Goh Xueying²,Siow Chor Hiang²,Goh Han Lee²,Goh Boon Cher³⁴⁵⁶,Cheo Timothy⁷,Loh Kwok Seng²,Brunham Liam R.¹⁸⁹^ORCID

Affiliation:

1. Translational Laboratory in Genetic Medicine, Agency for Science, Technology, and Research; Singapore

2. Department of Otolaryngology - Head and Neck Surgery; National University Health System; Singapore

3. Department of Haematology-Oncology, National University Cancer Institute; National University Health System; Singapore

4. Cancer Science Institute; Singapore

5. Department of Pharmacology, Yong Loo Lin School of Medicine; National University Health System; Singapore

6. Haematology Oncology Research Group, National University Cancer Institute; National University Health System; Singapore

7. Department of Radiation Oncology, National University Cancer Institute; National University Health System; Singapore

8. Department of Medicine, Centre for Heart Lung Innovation; University of British Columbia; Vancouver British Columbia Canada

9. Department of Medicine; National University of Singapore; Singapore

Funder

Biomedical Research Council of the Agency for Science, Technology, and Research of Singapore (Strategic Positioning Funds)

National University of Singapore

Clinician Scientist New Investigator

National Medical Research Council

Publisher

Wiley

Subject

Otorhinolaryngology

Reference32 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Advances in systemic treatment for nasopharyngeal carcinoma;Tan;Chin Clin Oncol,2016

3. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis;Blanchard;Lancet Oncol,2015

4. Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy;Ross;Nat Genet,2009

5. Pharmacogenomics of cisplatin-induced ototoxicity;Mukherjea;Pharmacogenomics,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevailing Practices in Ototoxicity Monitoring in Individuals With Head and Neck Cancer Undergoing Radiotherapy and Chemoradiotherapy: A Scoping Review;American Journal of Audiology;2024-09-03

2. Risk factors associated with ototoxicity in long-term nasopharyngeal carcinoma survivors;Oral Oncology;2024-07

3. Neurological complications of modern radiotherapy for head and neck cancer;Radiotherapy and Oncology;2024-05

4. Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy;Radiotherapy and Oncology;2024-01

5. Prevention and treatment of cisplatin‐induced ototoxicity in adults: A systematic review;Clinical Otolaryngology;2023-10-11